Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Disabling mutations in integrin-mediated cell signaling have been a major focus of interest over the last decade for patients affected with leukocyte adhesion deficiency-III (LAD-III).
|
25854317 |
2015 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency 1 (LAD-1) is caused by defects in the β2 integrin subunit.
|
25514840 |
2015 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Kindlin-3 is a novel integrin activator in hematopoietic cells, and its deficiency leads to immune problems and severe bleeding, known as leukocyte adhesion deficiency III (LAD-III).
|
22564402 |
2012 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Kindlin-3 is a key lymphocyte function-associated antigen-1 (LFA-1) coactivator deleted in leukocyte adhesion deficiency-III (LAD-III).
|
21536861 |
2011 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency 1 (LAD1) is an inherited disorder of neutrophil function.
|
21103413 |
2010 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Novel integrin-dependent platelet malfunction in siblings with leukocyte adhesion deficiency-III (LAD-III) caused by a point mutation in FERMT3.
|
20216991 |
2010 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In the disorder leukocyte adhesion deficiency III (LAD-III), integrins on platelets and leukocytes are expressed but fail to function and this leads to severe bleeding and infections at an early age.
|
20357244 |
2010 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
These symptoms are consistent with but more severe than those reported for people with leukocyte adhesion deficiency III (LAD-III).
|
19234460 |
2009 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency II (LAD II) belongs to a group of human congenital diseases in which the interactions of leukocytes with the vascular endothelium are strongly impaired.
|
16956371 |
2006 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency II (LAD II) is a rare congenital disease caused by defective fucosylation leading to immuno-deficiency and psychomotor retardation.
|
16455955 |
2006 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency II (LAD II) is a rare congenital disease which is caused by a defect in fucosylation of glycoconjugates.
|
12476046 |
2002 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency II (LAD II) is characterized by the lack of fucosylated glycoconjugates, including selectin ligands, causing immunodeficiency and severe mental and growth retardation.
|
11326279 |
2001 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency-1 (LAD-1) is the result of mutations in the beta2 subunit of the CD11/CD18 integrins, LFA-1, Mac-1, p150,95 and alphadbeta2.
|
10936446 |
2000 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Neutrophils isolated from a child with severe leukocyte adhesion deficiency 1 (LAD1) had a complete absence of expression of the CD11/CD18 beta2 integrin family of adhesion molecules, and were shown to be deficient in the in vitro adhesion and migration properties.
|
10564719 |
2000 |
Congenital leukocyte adherence deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
Leukocyte adhesion deficiency or LAD is a congenital immunodeficiency disease characterized by recurrent bacterial infections in which the leukocytes from affected children fail to adhere to endothelial cells and migrate to the site of infection due to heterogeneous defects in the leukocyte integrin CD18 subunit.
|
9473215 |
1998 |